(Reuters) -Pfizer will sell shares worth 2.50 billion pounds ($3.05 billion) in Haleon, lowering its stake in the British consumer healthcare company to about 7.3% from 15%, its bookrunner ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback